Editorial board member Professor Claudio Tondo (Professor of Cardiology, Centro Cardiologico Monzino, University of Milan, Milan, Italy) joins us at the annual European Heart Rhythm 2019 congress in Lisbon to discuss one of the latest emerging approaches to managing atrial fibrillation, balloon-based interventions.
Filmed at EHRA 2019, Lisbon.
Speaker’s Disclosures: Professor Claudio Tondo has no conflicts of interest related to this video.
- There are emerging approaches to managing atrial fibrillation – can you explain the various balloon technologies? (0:14)
- Which patients are most suited to balloon-based interventions and how these can benefit patients? (1:10)
- Convergent procedure is another new approach to atrial fibrillation ablation – can you describe this process? (1:50)
- How can a convergent procedure help overcome existing shortcomings and benefit patients? (2:42)
- Please tell us your hopes for this year’s EHRA congress? (4:01)
touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
Share this Video
Related Videos In Atrial Fibrillation
Faizel Osman, A-A Heart Rhythm Updates 2021: 2020 ESC AF Guidelines
We spoke to Professor Faizel Osman (Consultant Cardiologist and Electrophysiologist, University Hospital Coventry and Warwickshire NHS Trust, Coventry, UK) who gave us an update about the recent new ESC Guidelines for Atrial Fibrillation and the upcoming Arrhythmia Alliance Heart Rhythm Updates 2021. Questions What are the most important new recommendations in the 2020 ESC atrial […]
Suneet Mittal, AF Symposium 2021: Atrial Fibrillation in the Post-COVID-19 Environment
We spoke to Dr Suneet Mittal (Director of Electrophysiology, The Valley Hospital, Ridgewood, NJ, USA) about the workflow innovations for atrial fibrillation ablation in the post-COVID-19 environment. Questions What have been the main challenges to atrial fibrillation (AF) ablation workflow during the COVID-19 pandemic? (0.14) What workflow innovations have been created and incorporated over the […]
Hugh Calkins, AF Symposium 2021: the STOP Persistent AF Clinical Trial
We spoke to Professor Hugh Calkins (Johns Hopkins Hospital, Baltimore, MD, USA) about the STOP Persistent AF Clinical Trial (NCT03012841). Questions: Could you tell us a little about the aims and design of the STOP Persistent AF clinical trial? (0.13) What were the findings of the study? (0.43) What are their implications for clinical practice? […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!